CNTB vs NTAP · rev $64.0K vs P/E 28, rev $6.24B
Connect Biopharma Holdings Ltd (CNTB) versus NetApp Inc (NTAP) — a side-by-side from cached financials, not a winner call.
Connect Biopharma Holdings Ltd (CNTB) is a biotechnology company listed on US.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Latest reported CNTB revenue for 2025-12-31 was $64.0K. Net income was -$55.5M. Revenue was down 99.8% from 2024-12-31 to 2025-12-31. CNTB currently screens at market cap $63.3M.
Latest reported NTAP revenue for 2026-04-24 was $6.24B. Net income was $1.28B. Revenue was down 5.1% from 2025-04-25 to 2026-04-24. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
CNTB currently screens at market cap $63.3M. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Not investment advice. Open the CNTB and NTAP stock pages for the full models.
Not investment advice.